Tomáš Milota (Tomas Milota)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 10

Top Topics

Coronavirus Disease

Inflammatory Response

Ankylosing Spondylitis

Top Venues

Pharmaceuticals (Basel, Switzerland)

Pathogens (Basel, Switzerland)

Therapeutic advances in musculoskeletal disease

This page only lists publications with an associated author ORCID identifier.

Publications

Tomáš Milota, Jitka Smetanova, Jirina Bartunkova
Clinical Outcome of Coronavirus Disease 2019 in Patients with Primary Antibody Deficiencies. Pathogens (Basel, Switzerland) 12 (1) (2023)
Iveta Klojdová, Tomáš Milota, Jitka Smetanová, Constantinos Stathopoulos
Encapsulation: A Strategy to Deliver Therapeutics and Bioactive Compounds? Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Tomáš Milota, Jitka Smetanova, Jirina Bartunkova
Clinical Outcome of Coronavirus Disease 2019 in Patients with Primary Antibody Deficiencies. Pathogens (Basel, Switzerland) 12 (1) (2023)
Iveta Klojdová, Tomáš Milota, Jitka Smetanová, Constantinos Stathopoulos
Encapsulation: A Strategy to Deliver Therapeutics and Bioactive Compounds? Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Tomáš Milota, Jitka Smetanova, Jirina Bartunkova
Clinical Outcome of Coronavirus Disease 2019 in Patients with Primary Antibody Deficiencies. Pathogens (Basel, Switzerland) 12 (1) (2023)
Iveta Klojdová, Tomáš Milota, Jitka Smetanová, Constantinos Stathopoulos
Encapsulation: A Strategy to Deliver Therapeutics and Bioactive Compounds? Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Tomáš Milota, Jana Hurnakova, Karel Pavelka, Zlatuse Kristkova, Lucie Nekvindova, Rudolf Horvath
Delayed treatment with a tumor necrosis factor alpha blocker associated with worse outcomes in patients with spondyloarthritis: data from the Czech National Registry ATTRA. Therapeutic advances in musculoskeletal disease 14 (2022)
Martin Wasserbauer, Štěpán Hlava, Milan Trojanek, Jan Stovicek, Tomáš Milota, Jiri Drabek, Petra Koptová, Andrea Cupkova, Dita Pichlerová, Barbora Kucerova, Stepan Coufal, Radan Keil
Efficacy and safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive and biological therapy: Prospective observational study. PloS one 17 (9) (2022)
Anna Šedivá, Tomáš Milota, Jiří Litzman, Isabella Quinti, Isabelle Meyts, Siobhan Burns, Stephen Jolles
Medical algorithm: Diagnosis and management of antibody immunodeficiencies. Allergy 76 (12) (2021)
Mark James Ponsford, Adam Klocperk, Federica Pulvirenti, Virgil A S H Dalm, Tomáš Milota, Francesco Cinetto, Zita Chovancova, Manuel J Rial, Anna Sediva, Jiri Litzman, Carlo Agostini, Martin van Hagen, Isabella Quinti, Stephen Jolles
Hyper-IgE in the allergy clinic--when is it primary immunodeficiency? Allergy 73 (11) (2018)